Johnson & Johnson (JNJ) debt
What Johnson & Johnson owes, when it comes due, and what it costs to carry, from the balances and cash flows the company reports to the U.S. Securities and Exchange Commission.
At a glance
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Total debt | $44.65B | $45.80B | −$1.14B |
| Due within a year | $8.85B | $6.39B | +$2.46B |
| Long-term debt | $35.80B | $39.41B | −$3.61B |
| Cash and equivalents | $16.91B | $18.23B | −$1.32B |
| Net debt | $27.74B | $27.56B | +$177M |
Total debt is the sum of the debt lines the company reports at that date (long-term, current and short-term borrowings), not a figure the company reports as a total.
Debt over time
| Balance date | Total debt | Due within a year | Long-term debt | Cash |
|---|---|---|---|---|
| Sep 2026 | $44.65B† | $8.85B | $35.80B | $16.91B |
| Jun 2026 | $49.04B† | $11.69B | $37.34B | $20.42B |
| Mar 2026 | $54.99B† | $17.46B | $37.53B | $21.69B |
| Dec 2025 | $47.94B† | $8.50B | $39.44B | $19.71B |
| Sep 2025 | $45.80B† | $6.39B | $39.41B | $18.23B |
| Jun 2025 | $50.76B† | $11.53B | $39.23B | $18.58B |
| Mar 2025 | $52.25B† | $13.90B | $38.35B | $38.47B |
| Dec 2024 | $36.65B† | $6.00B | $30.65B | $24.11B |
| Sep 2024 | $35.75B† | $4.46B | $31.29B | $19.98B |
| Jun 2024 | $41.49B† | $9.86B | $31.64B | $24.88B |
| May 2024 | — | $3.60B | — | — |
| Mar 2024 | $33.63B† | $8.55B | $25.08B | $25.47B |
† Sum of the debt lines the company reports at that date, not a reported total.
When it comes due
Principal due by year as of December 28, 2025.
| Due | Principal | Share of total |
|---|---|---|
| Within 1 year | $2.00B | 4.8% |
| Year 2 | $3.22B | 7.8% |
| Year 3 | $3.13B | 7.5% |
| Year 4 | $2.15B | 5.2% |
| Year 5 | $2.69B | 6.5% |
| After year 5 | $28.25B | 68.2% |
| Total | $41.44B | 100% |
Interest cost and borrowing
| Fiscal year | Interest expense | Borrowed | Repaid |
|---|---|---|---|
| FY Dec 2025 | $971M | $9.14B | $1.76B |
| FY Dec 2024 | $755M | $6.66B | $1.45B |
| FY Dec 2023 | $772M | $0 | $1.55B |
| FY Jan 2023 | $276M | $2M | $2.13B |
| FY Jan 2022 | $183M | $5M | $1.80B |
* Fiscal fourth quarter computed from the annual filing minus the three reported quarters.
About these figures
These are the balances Johnson & Johnson reports in its SEC filings as of each balance-sheet date, and the interest, borrowing and repayments it reports for each period. This page does not show market prices or yields of the company's bonds. "Long-term debt" is the line as the company tags it in its filings and may or may not include the portion due within a year.
All figures from company filings with the SEC.